Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors

Ähnliche Einträge

• Exploring new quinazolin‐4(3H)‐one derivatives as CDK2 inhibitors: Design, synthesis, and anticancer evaluation
  von: Basant T. Ibrahim, et al.
  Veröffentlicht: (2024)
• Quinazoline‐oxindole hybrids as angiokinase inhibitors and anticancer agents: Design, synthesis, biological evaluation, and molecular docking studies
  von: Yasmin M. Syam, et al.
  Veröffentlicht: (2024)
• Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity
  von: Heba T. Abdel‐Mohsen, et al.
  Veröffentlicht: (2024)
• Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells
  von: Francesco Berluti, et al.
  Veröffentlicht: (2024)
• Completed Dyadic Zeta Functions with Cosine and Sine Kernels: Functional Symmetry and Zero Distributions Modeled on Riemann's ξ(s)
  von: Odeh, Salaheddin
  Veröffentlicht: (2025)